Meeting research needs with postmortem biospecimen donation: Summary of recommendations for postmortem recovery of normal human biospecimens for research

Biopreservation and Biobanking

Volumn 11, Issue 2, 2013, Pages 77-82

  Mucci, Neil R ^a   Moore, Helen M ^a   Brigham, Lori E ^a   Goldthwaite, Charles A ^a   Roger Little, A ^a   Lockhart, Nicole C ^a   Scott, Michael P ^a   Struewing, Jeffery P ^a   Vincent, Stephen L ^a   Compton, Carolyn C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CADAVER; CLINICAL PRACTICE; COMMUNITY; DONOR; FAMILY; HUMAN; HUMAN TISSUE; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; TISSUE CULTURE; TISSUE SECTION; UNITED STATES; AUTOPSY; DEMOGRAPHY; ETHICS; HEALTH CARE FACILITY; LEGISLATION AND JURISPRUDENCE; POSTMORTEM CHANGE; PRACTICE GUIDELINE; SOCIAL CONTROL;

AUTOPSY; BIOMEDICAL RESEARCH; FAMILY; GUIDELINES AS TOPIC; HUMANS; POSTMORTEM CHANGES; QUALITY CONTROL; RESIDENCE CHARACTERISTICS; SOCIAL CONTROL, FORMAL; TISSUE BANKS; TISSUE DONORS;

EID: 84876950228     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2012.0063     Document Type: Article

References (34)

1. National biospecimen network blueprint. Durham NC: Constella Group, Inc.; 2003. Available at http://biospecimens.cancer.gov/global/pdfs/FINAL-NBN- Blueprint.pdf.
2. United States Department of Health and Human Services. Personalized healthcare: Opportunities, pathways, resources. http://www.hhs.gov/myhealthcare/ news/phc-report.pdf. Accessed May 25, 2010.
3. President's Council of Advisors on Science and Technology. Priorities for personalized medicine. http://www.whitehouse .gov/files/documents/ostp/PCAST/ pcast-report-v2.pdf. Accessed May 25, 2010.
4. President's Cancer Panel. Maximizing our Nation's Investment in Cancer: Three Crucial Actions for America's Health. Washington DC: United States Department of Health and Human Services; 2008.
5. Institute of Medicine. Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment. Washington DC: National Academies Press; 2007.
6. Park A. Ten ideas that are changing the world today: Biobanks. Time 2009 (March 23).
7. National Cancer Institute, Office of Biorepositories and Biospecimen Research. National Cancer Institute Best Practices for Biospecimen Resources. http://biospecimens.cancer.gov/bestpractices/. Accessed August 29, 2012.
8. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr Res 2000;44:151-155. (Pubitemid 30411930)
9. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Med 1997;121:615-618.
10. Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Res 2004;64:9209-9216. (Pubitemid 39665537)
11. Rubin MA, Putzi M, Mucci N, et al. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000;6:1038-1045. (Pubitemid 30159365)
12. Pentz RD, Cohen CB, Wicclair M, et al. Ethics guidelines for research with the recently dead. Nat Med 2005;11:1145-1149. (Pubitemid 43093654)
13. Health Resources and Services Administration. The National Organ Transplantation Act (as amended by the Charlie W. Norwood Living Organ Donation Act-January 2008). http://www.hods.org/english/h-issues/documents/NOTA-as- amended- - -Jan-2008.pdf Accessed January 21, 2013.
14. United Network for Organ Sharing. Policy 2.0: Minimum procurement standards for an organ procurement organization (OPO). http://optn.transplant. hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-2.pdf. Accessed Jan 21, 2013.
15. National Conference of Commissioners on Uniform State Laws. Uniform Anatomical Gift Act. http://www.uniformlaws.org/Shared/Docs/./UAGA-Final-NC.doc. Accessed January 21, 2013.
16. United States Department of Health & Human Services, United States Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). http://www.fda.gov/downloads/Biologics BloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ UCM091408.pdf. Accessed May 17, 2010.
17. Standards for on-Transplant Anatomical Donation for Education and/or Research, 1st Edition, Dec 2011, American Association of Tissue Banks.
18. Agilent Technologies, Mueller O, Lightfoot S, Schroeder A. RNA integrity number (RIN)-Standardization of RNA quality control. http://www.biomedcentral. com/1471-2199/7/3/Accessed January 21, 2013.
19. Schroeder A, Mueller O, Stocker S, et al. The RIN: An RNA integrity number for assigning integrity values to RNA measurements BMC Mol Biol 2006;7:3.
20. Stan AD, Ghose S, Gao XM, et al. Human postmortem tissue: What quality markers matter? Brain Res 2006;1123:1-11.
21. Durrenberger PF, Fernando S, Kashefi SN, et al. Effects of antemortem and postmortem variables on human brain mRNA quality: A BrainNet Europe Study. J Neuropathol Exp Neurol 2010;69:70-81.
22. Steinbrook R. Organ donation after cardiac death. New Engl J Med 2007;357:209-213. (Pubitemid 47080384)
23. McKeel D. The role of agonal factors in human post mortem CNS research. St. Louis: Washington University School of Medicine; 2004.
24. Li JZ, Vawter MP, Walsh DM, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 2004; 13:609-616. (Pubitemid 38379850)
25. Preece P, Carins NJ. Quantifying mRNA in postmortem human brain: Influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 2003;118:60-71. (Pubitemid 37238988)
26. Ervin JF, Heinzen EL, Cronin KD, et al. Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol 2007;66:1093-1099. (Pubitemid 350294659)
27. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A. The patients dying after long terminal phase have acidotic brains: Implications for biochemical measures on autopsy tissue. J Neural Transm 1985;61:253-264. (Pubitemid 15138171)
28. Miller CL, Diglisic S, Leister F, Webster M, Yolken RY. Evaluating RNA status for RT-PCR in extracts of post-mortem human brain tissue. Biotechniques 2004;36:628-633. (Pubitemid 38451647)
29. United States Department of Health & Human Services. Code of Federal Regulations-Title 45 (Public welfare), Part 46 (Protection of human subjects). http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Accessed January 21, 2013.
30. Yasko LL, Wicclair M, DeVita MA. Committee for Oversight of Research Involving the Dead (CORID): Insights from the first year. Camb Q Healthc Ethics 2004;13:327-337. (Pubitemid 39420946)
31. United Network for Organ Sharing. Fact sheet: Donor designation (first person consent) status by state. http://www .unos.org/docs/registires-combined. pdf. Accessed January 21, 2013.
32. Lindell KO, Erlen JA, Kaminski N. Lessons learned from our patients: Development of a warm autopsy program. PLoS Med 2006;3:e234.
33. Wicclair MR, DeVita M. Oversight of research involving the dead. Kennedy Inst Ethics J 2004;14:143-164. (Pubitemid 38834538)
34. OrganDonor.gov. Religious views on donation. http://www.organdonor.gov/ about/religiousviews.html. Accessed January 21, 2013.